The prevalence and prognosis of hyponatraemia in non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis

Leuk Lymphoma. 2022 Feb;63(2):362-369. doi: 10.1080/10428194.2021.1992623. Epub 2021 Oct 18.

Abstract

Non-Hodgkin lymphoma associated hemophagocytic lymphohistiocytosis (NHL-HLH) in adult secondary HLH is a common and universally highly lethal critical disorder. Hyponatraemia is the most common electrolyte disorder in the critical illness setting and acts as a negative prognostic factor. The aim of our study was to evaluate the prognostic role of hyponatraemia among patients with NHL-HLH. The results showed that 81 (52.9%) patients had hyponatraemia. After a median follow up 47 (range 14-180) days, there were 72 (88.9%) cumulative deaths in hyponatraemia group while 50 (69.4%) in normonatremia group. After adjustment for confounders, multivariate analysis revealed that hyponatraemia was an independent prognostic factor for OS (HR:1.51, 95% CI: 1.03-2.20; p = 0.033). Restricted cubic spline confirmed a linear and positive association between serum sodium and the risk of mortality. Hyponatraemia is relatively frequent in NHL-HLH. As a readily available biomarker in clinical routine, it was a promising prognostic predictor for NHL-HLH.

Keywords: Hemophagocytic lymphohistiocytosis; hyponatraemia; non-Hodgkin lymphoma; prognosis; survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Humans
  • Hyponatremia* / diagnosis
  • Hyponatremia* / epidemiology
  • Hyponatremia* / etiology
  • Lymphohistiocytosis, Hemophagocytic* / diagnosis
  • Lymphohistiocytosis, Hemophagocytic* / epidemiology
  • Lymphohistiocytosis, Hemophagocytic* / etiology
  • Lymphoma, Non-Hodgkin* / complications
  • Lymphoma, Non-Hodgkin* / diagnosis
  • Prevalence
  • Prognosis
  • Retrospective Studies